A novel TWIK2 channel inhibitor binds at the bottom of the selectivity filter and protects against LPS-induced experimental endotoxemia in vivo.
A novel TWIK2 channel inhibitor binds at the bottom of the selectivity filter and protects against LPS-induced experimental endotoxemia in vivo.
复制标题
DOI:
10.1016/j.bcp.2023.115894
复制
发表时间:
2023-10
影响因子:
5.8
通讯作者:
Yuanxing Zhi;Xiaoyan Wu;Yanshan Chen;Xingyuan Chen;Xiangyu Chen;Hui Luo;Xin Yi;Xiuling Lin;Liang Ma;Yao Chen;Ying Cao;Fengxian Li;Pingzheng Zhou
中科院分区:
文献类型:
--
作者:
Yuanxing Zhi;Xiaoyan Wu;Yanshan Chen;Xingyuan Chen;Xiangyu Chen;Hui Luo;Xin Yi;Xiuling Lin;Liang Ma;Yao Chen;Ying Cao;Fengxian Li;Pingzheng Zhou
TWIK2 channel plays a critical role in NLRP3 inflammasome activation and mice deficient in TWIK2 channel are protected from sepsis and inflammatory lung injury. However, inhibitors of TWIK2 channel are currently in an early stage of development, and the molecular determinants underlying the chemical modulation of TWIK2 channel remain unexplored. In this study, we identifiedNPBAand the synthesized derivativeNPBA-4potently and selectively inhibited TWIK2 channel by using whole-cell patch clamp techniques. Furthermore, the mutation of the last residues of the selectivity filter in both P1 and P2 (i.e., T106A, T214A) of TWIK2 channel substantially abolished the effect ofNPBAon TWIK2 channel. Our data suggest thatNPBAblocked TWIK2 channel through binding at the bottom of the selectivity filter, which was also supported by molecular docking prediction. Moreover, we found thatNPBAsignificantly suppressed NLRP3 inflammasome activation in macrophages and alleviated LPS-induced endotoxemia and organ injury in vivo. Notably, the protective effects ofNPBAagainst LPS-induced endotoxemia were abolished inKcnk6-/-mice. In summary, our study has uncovered a series of novel inhibitors of TWIK2 channel and revealed their distinct molecular determinants interacting TWIK2 channel. These findings provide new insights into the mechanisms of pharmacological action on TWIK2 channel and opportunities for the development of selective TWIK2 channel modulators to treat related inflammatory diseases.